Interacting Drugs |
Ibritumomab vs Vitamin K Antagonists (eg, warfarin) |
Security Level |
|
Mechanism |
Vitamin K Antagonists (eg, warfarin): Antineoplastic Agents may enhance the anticoagulant effect of Vitamin K Antagonists. Antineoplastic Agents may diminish the anticoagulant effect of Vitamin K Antagonists. |
Management |
Monitor therapy |
Ibritumomab vs Vitamin K Antagonists (eg, warfarin)
Post Review about Ibritumomab vs Vitamin K Antagonists (eg, warfarin) Click here to cancel reply.
Other Interactions of Ibritumomab
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.